Investing and innovating alongside entrepreneurs

SGX partners CBA to facilitate fund raising for entrepreneurs and SME

Click Here

click here to stay informed

About us

Clearbridge Accelerator is a Singapore leading incubation firm that invests in game-changing healthcare, infosecurity and technology companies. We have a strong track record in leading early stage investments, partnering with visionary entrepreneurs and world-leading institutions.

We invest in and back entrepreneurs with breakthrough innovations and businesses.

Our team consists of serial entrepreneurs with deep domain expertise, extensive networks and operational experience in key markets such as the US, China, Japan and Australia.

Via a public-private partnership with the Singapore Government, Clearbridge Accelerator manages both a SGD 40 MM scheme to invest in life science companies (SPRING SSC BSA), and an incubator scheme that invests up to SGD 1 MM for Seed-stage companies (NRF TIS).

Strategically headquartered in Singapore, Clearbridge Accelerator is committed to grow Asian companies globally, and to support international companies entering key Asian markets.

Management Team   |   Affiliated Partners   |   Directors   |   Advisory Board

Management Team

Johnson Chen
Managing Partner

Chong Chee Wah

Dr Steven Fang

Johnson Chen
Managing Partner

Mr Chen is the Managing Partner for Clearbridge Partners, an Asian venture capital firm. He is also the Managing Partner for Clearbridge Accelerator, a Singapore National Research Foundation (NRF) backed high-technology incubator and an investment committee member of Clearbridge BSA Pte Ltd.

Prior to founding Clearbridge, Mr Chen worked at Pacific Century CyberWorks Limited, the incumbent and leading telecommunications company in Hong Kong. Mr Chen is a member of the pioneering team at PCCW and was the President of CyberWorks Ventures, the Venture Capital and direct investment arm of PCCW. Mr Chen was also the youngest member of PCCW's Mergers & Acquisitions executive committee, and was responsible for much of PCCW's strategic expansion and many of its successful acquisitions and investments.

Mr Chen has more than 12 years of entrepreneurship experience with start-ups, being the co-founder of 2 start-up companies with successful exits. Mr Chen has also given talks on entrepreneurship in Hong Kong and the United States, including the Sloan School of Management at MIT. Mr Chen is an active angel investor and was a member of the Hong Kong Science and Technology Park (HKSTP) incubator selection panel and a venture committee member of the Hong Kong Venture Capital and Private Equity Association (HKVCA). He is also currently a member of the Singapore NRF POC grant panel.

Mr Chen is the recipient of the prestigious Sword of Honour from the Singapore Armed Forces, and holds a B.A., M.A. and M.Eng from the University of Cambridge, (U.K.).

Chong Chee Wah

Mr Chong previously worked as a Communications Security Program Manager at the DSO National Laboratories. He won the prestigious KINETIC Award in DSO for his outstanding technical contributions to various initiatives in the defence sector. He oversaw various cryptographic and communication systems as well as direct research & development investments in excess of S$5 million annually. He was also the key technical decision maker on various national level projects.

Prior to working at DSO, Mr Chong was with the Directorate of Research & Development (under the Defence Science & Technology Agency) as a Country Manager, where he was responsible for the long term strategic R&D plans for the Ministry of Defence. Mr Chong was also the Assistant Director of Finance Policy at the Ministry of Health (MOH) where his responsibilities included policy matters on Singapore's key medical financial schemes.

Mr Chong is the recipient of the Public Service Commission's Local Merit Scholarship and has a B.Eng and M.Eng (Electrical Engineering) from the National University of Singapore.

Dr Steven Fang

Dr Fang has over two decades of experience in growing life sciences businesses. Dr Fang was the Group CEO of CordLife Ltd, a cord blood banking group based in Singapore. CordLife was founded in May 2001 by Dr Fang, and has since grown to have five cord blood processing and storage facilities, in Singapore, Hong Kong, Jakarta, Indonesia, Kolkata, India, and in Sydney, Australia. The company was listed on the Australian Stock Exchange in 2004, and spun off a separate entity in 2010, which subsequently was listed on the Singapore Stock Exchange. Prior to CordLife, Dr Fang held various management positions in life sciences companies such as Becton Dickinson, Baxter Healthcare and Sterling Pharmaceuticals (now part of GSK).

Dr Fang is very active within Singapore's entrepreneurship and biomedical sciences sectors. He has played a key role in various committees and organisations, including:

  • Co-Chairman Tech-Connect Task Force, which aims to encourage more commercialisation of public and private sector R&D, as Singapore moves into higher value-added activities
  • Deputy Chairman, Action Community for Entrepreneurship (ACE) & Chairman ACE Mentoring sub-committee, Singapore Ministry of Trade & Industry, which aims to seed and nurture Singapore entrepreneurial start-ups
  • Advisory Member, A*STAR ETPL Diagnostic Hotspot Panel
  • Member of the Pro-Enterprise Panel, which aims to actively solicit feedback on rules and regulations that hinder businesses and stifle entrepreneurship
  • Past President/ Board of Governors, Spirit of Enterprise, which promotes and advances entrepreneurial spirit in Singapore
  • Member, Nanyang Polytechnic's Life Science Advisory Committee
  • Founding Council Member/ Past Chairman BioSingapore, an industry association for life sciences businesses in Singapore
Dr Fang has also received a number of awards, including the Technology Pioneer Award Life Science, Ernst & Young Entrepreneur of the Year (New Enterprise), Spirit of Enterprise and the Asia Pacific Entrepreneurship Award's Outstanding Entrepreneur Award.

Latest News

The Straits Times, 16 September 2016

Every cell counts in fine-tuning treatment of cancer

A cell-capturing chip that allows researchers to analyse individual cancer cells could pave the way for doctors to better profile and diagnose cancer patients, its creators believe.

Biotechin.Asia, 29 June 2016

Clearbridge Accelerator & Cambridge Consultants partner to help MedTech startups to fast track to market!

Product design and development company Cambridge Consultants is teaming up with Singapore incubation firm Clearbridge Accelerator to create a 'one-stop shop' for medical technology start-ups in the region.

The Straits Times, 8 April 2016

Capbridge gets license to help firms secure funds

The Capital Markets & Services Licence (CMSL) allows CapBridge connect investors to high-tech companies aiming to raise at least USD10 million (SGD13.5 million).

Ops! Error message here

Great! Success message here

Hey! Please try again!


Clearbridge Accelerator has an exciting portfolio of companies which are in various stages of development. We need independent, creative and highly passionate people to join us on this journey as we incubate and grow our portfolio into world-class companies. We are looking for exceptional individuals who believe they can make a difference.

If you have the confidence and passion to work in start up environments, enjoy constant and dynamic challenges, and want to make an impact in your career, we welcome you to send your resume to:

Contact Us

Contact Us

A. 81 Science Park Drive, #02-03 The Chadwick, Singapore Science Park 1, Singapore 118257

T. +65 6873 0668
F. +65 6873 0778

Find us on map